Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Arcus Biosciences, Inc.
Arcus Biosciences Appoints Dimitry Nuyten, M.D., Ph.D. as Chief Medical Officer
August 08, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Reports Second Quarter 2022 Financial Results and Provides a Pipeline Update
August 03, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
July 26, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Reports First Quarter 2022 Financial Results and Provides a Pipeline Update, Including from the Third Interim Analysis for the ARC-7 Study
May 09, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
April 11, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
March 24, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
February 24, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
February 23, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
January 11, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones
January 10, 2022
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Gilead and Arcus Biosciences Complete Closing of Option Exercise for Three Clinical-Stage Programs and New Research Collaboration
December 21, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
GILD
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
December 09, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Taiho Pharmaceutical Exercises Option for an Exclusive License to Arcus Biosciences’ Anti-TIGIT Program in Japan and Certain Territories in Asia
November 30, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Arcus Biosciences to Participate in the Upcoming Evercore ISI HealthCONx 2021 Conference
November 22, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
November 09, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Reports Third Quarter 2021 Financial Results and Provides an Update on our anti-TIGIT Domvanalimab
November 08, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Arcus Biosciences to Report Third Quarter 2021 Financial Results & Recent Corporate Highlights
November 02, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
September 09, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
August 24, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
August 10, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Reports Second Quarter 2021 Financial Results and Provides Operational Highlights
August 05, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
July 26, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
May 25, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
April 26, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Presents Updated Data for Etrumadenant in Third-Line Metastatic Colorectal Cancer and New Data on its HIF-2α Program at the AACR 2021 Annual Meeting
April 10, 2021
From
Arcus Biosciences, Inc.
Via
Business Wire
Tickers
RCUS
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.